Consainsights logo
Reports / Sulphonamides Market

Sulphonamides Market

Sulphonamides Market Research Report – Segmented By Route of Administration (Oral, Topical), Application (Gastro Intestinal Tract (GIT) Infection, Others, Respiratory Tract Infection (RTI), Skin Infections, Urinary Tract Infection (UTI)) & Region (North America, Europe, APAC, Latin America, Middle East and Africa) – Analysis on Size, Share, Trends, COVID-19 Impact, Competitive Analysis, Growth Opportunities and Key Insights from 2017 to 2026.


01

Executive Summary

Sulphonamides Market was valued at US $43.70 billion in 2021 and is projected to grow at 5.19% CAGR over the forecast period to reach US $59.21 billion by 2027. Sulphonamides Market represented US $4.21 billion opportunity over 2019-2021 and estimated to create US $15.51 billion opportunity in 2027 over 2021.

Sulphonamides from Consainsights analyses the Sulphonamides Market in the Life Sciences industry over the forecast period to 2027.

Sulphonamides research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

Sulphonamides segmentation includes Route of Administration, Application and Geography.

Based on the Route of Administration, the Sulphonamides analysis covers Oral, Topical.

In Route of Administration segment, Oral segment has highest cagr growth of 4.60%.

Based on the Application, the Sulphonamides analysis covers Skin Infections, Gastro Intestinal Tract (GIT) Infection, Urinary Tract Infection (UTI), Respiratory Tract Infection (RTI), Others.

In Application segment, Skin Infections segment has highest cagr growth of 4.60%.

Based on the region, the Sulphonamides analysis covers North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America.

Key companies operating in the market include AA Pharma Inc., Abbott Laboratories, F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc, Lexine Technochem Pvt. Ltd., Mylan Pharmaceuticals, Pfizer Inc., Teva Pharmaceuticals USA, Inc. and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

  • Revenue Share (%), By Route of Administration (2021)
    Revenue Share (%), By Route of Administration (2021)
  • Revenue Share (%), By Application (2021)
    Revenue Share (%), By Application (2021)
02

Market Overview

  • The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.
  • The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.
  • The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.
  • Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.
  • Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.
  • As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.
  • The currency used in this report is USD, with the market size indicated in terms of USD million/billion.
  • For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.
  • For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD Market Definition.
03

By Route of Administration

  • Oral accounted for US$30.52 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Topical accounted for US$13.18 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
Sulphonamides Market Y-o-Y Growth (USD billion), By Route of Administration 2019 - 2027
Sulphonamides Market Y-o-Y Growth (USD billion), By Route of Administration 2019 - 2027
Sulphonamides Market Size, By Route of Administration, 2019-2027 (USD billion)
Sulphonamides Market Size, By Route of Administration, 2019-2027 (USD billion)

The Oral segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Oral: global Sulphonamides Market Revenue Opportunity (Us$ Mn)
Oral: global Sulphonamides Market Revenue Opportunity (Us$ Mn)

The Topical segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Topical: global Sulphonamides Market Revenue Opportunity (Us$ Mn)
Topical: global Sulphonamides Market Revenue Opportunity (Us$ Mn)
04

By Application

  • Skin Infections accounted for US$18.06 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Gastro Intestinal Tract (GIT) Infection accounted for US$11.32 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Urinary Tract Infection (UTI) accounted for US$8.58 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Respiratory Tract Infection (RTI) accounted for US$5.31 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Others accounted for US$0.42 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
Sulphonamides Market Y-o-Y Growth (USD billion), By Application 2019 - 2027
Sulphonamides Market Y-o-Y Growth (USD billion), By Application 2019 - 2027
Sulphonamides Market Size, By Application, 2019-2027 (USD billion)
Sulphonamides Market Size, By Application, 2019-2027 (USD billion)

The Gastro Intestinal Tract (GIT) Infection segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Gastro Intestinal Tract (GIT) Infection: global Sulphonamides Market Revenue Opportunity (Us$ Mn)
Gastro Intestinal Tract (GIT) Infection: global Sulphonamides Market Revenue Opportunity (Us$ Mn)

The Others segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Others: global Sulphonamides Market Revenue Opportunity (Us$ Mn)
Others: global Sulphonamides Market Revenue Opportunity (Us$ Mn)

The Respiratory Tract Infection (RTI) segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Respiratory Tract Infection (RTI): global Sulphonamides Market Revenue Opportunity (Us$ Mn)
Respiratory Tract Infection (RTI): global Sulphonamides Market Revenue Opportunity (Us$ Mn)

The Skin Infections segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Skin Infections: global Sulphonamides Market Revenue Opportunity (Us$ Mn)
Skin Infections: global Sulphonamides Market Revenue Opportunity (Us$ Mn)

The Urinary Tract Infection (UTI) segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Urinary Tract Infection (UTI): global Sulphonamides Market Revenue Opportunity (Us$ Mn)
Urinary Tract Infection (UTI): global Sulphonamides Market Revenue Opportunity (Us$ Mn)
05

North America

  • In 2021, North America segment accounted for US$43.70 Bn and is expected grow with a CAGR of 5.19% over the forecast years.
  • In North America, United States accounted for US$25.08 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Canada accounted for US$18.62 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
North America Sulphonamides Market, By Country, 2019-2027 (USD billion)
North America Sulphonamides Market, By Country, 2019-2027 (USD billion)
North America Sulphonamides Market - Market Opportunity (USD billion), 2019, 2021 & 2027
North America Sulphonamides Market - Market Opportunity (USD billion), 2019, 2021 & 2027
Revenue Share (%), By Route of Administration - North America (2021)
Revenue Share (%), By Route of Administration - North America (2021)
Revenue Share (%), By Application - North America (2021)
Revenue Share (%), By Application - North America (2021)
North America Sulphonamides Market, By Country, 2019-2027 (USD billion)
North America Sulphonamides Market, By Country, 2019-2027 (USD billion)
United States Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
United States Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
United States Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
United States Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
Canada Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
Canada Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
Canada Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
Canada Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
06

Europe

  • In 2021, Europe segment accounted for US$43.70 Bn and is expected grow with a CAGR of 5.19% over the forecast years.
  • In Europe, Germany accounted for US$17.27 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • United Kingdom accounted for US$11.46 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • France accounted for US$5.95 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Spain accounted for US$4.92 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Russia accounted for US$2.83 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Italy accounted for US$1.01 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Rest of Europe accounted for US$0.27 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
Europe Sulphonamides Market, By Country, 2019-2027 (USD billion)
Europe Sulphonamides Market, By Country, 2019-2027 (USD billion)
Europe Sulphonamides Market - Market Opportunity (USD billion), 2019, 2021 & 2027
Europe Sulphonamides Market - Market Opportunity (USD billion), 2019, 2021 & 2027
Revenue Share (%), By Route of Administration - Europe (2021)
Revenue Share (%), By Route of Administration - Europe (2021)
Revenue Share (%), By Application - Europe (2021)
Revenue Share (%), By Application - Europe (2021)
Europe Sulphonamides Market, By Country, 2019-2027 (USD billion)
Europe Sulphonamides Market, By Country, 2019-2027 (USD billion)
Germany Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
Germany Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
Germany Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
Germany Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
United Kingdom Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
United Kingdom Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
United Kingdom Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
United Kingdom Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
France Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
France Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
France Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
France Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
Spain Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
Spain Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
Spain Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
Spain Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
Russia Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
Russia Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
Russia Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
Russia Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
Italy Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
Italy Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
Italy Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
Italy Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
Rest of Europe Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
Rest of Europe Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
Rest of Europe Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
Rest of Europe Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
07

Asia-Pacific

  • In 2021, Asia-Pacific segment accounted for US$43.70 Bn and is expected grow with a CAGR of 5.19% over the forecast years.
  • In Asia-Pacific, China accounted for US$19.39 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Japan accounted for US$10.17 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • India accounted for US$7.16 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Southeast Asia accounted for US$2.91 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Australia & New Zealand accounted for US$2.66 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Rest of Asia-Pacific accounted for US$1.40 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
Asia-Pacific Sulphonamides Market, By Country, 2019-2027 (USD billion)
Asia-Pacific Sulphonamides Market, By Country, 2019-2027 (USD billion)
Asia-Pacific Sulphonamides Market - Market Opportunity (USD billion), 2019, 2021 & 2027
Asia-Pacific Sulphonamides Market - Market Opportunity (USD billion), 2019, 2021 & 2027
Revenue Share (%), By Route of Administration - Asia-Pacific (2021)
Revenue Share (%), By Route of Administration - Asia-Pacific (2021)
Revenue Share (%), By Application - Asia-Pacific (2021)
Revenue Share (%), By Application - Asia-Pacific (2021)
Asia-Pacific Sulphonamides Market, By Country, 2019-2027 (USD billion)
Asia-Pacific Sulphonamides Market, By Country, 2019-2027 (USD billion)
China Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
China Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
China Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
China Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
Japan Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
Japan Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
Japan Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
Japan Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
India Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
India Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
India Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
India Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
Southeast Asia Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
Southeast Asia Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
Southeast Asia Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
Southeast Asia Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
Australia & New Zealand Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
Australia & New Zealand Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
Australia & New Zealand Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
Australia & New Zealand Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
Rest of Asia-Pacific Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
Rest of Asia-Pacific Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
Rest of Asia-Pacific Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
Rest of Asia-Pacific Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
08

Middle East & Africa

Based on the Middle East & Africa, the Sulphonamides Market analysis covers Middle East, Africa, Rest of Middle East & Africa.

Middle East & Africa Map
Middle East & Africa Sulphonamides Market Size, 2019-2027 (Us$ Mn)
Middle East & Africa Sulphonamides Size, 2019-2027 (Us$ Mn)
Middle East & Africa Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
Middle East & Africa Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
Middle East & Africa Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
Middle East & Africa Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
Middle East Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
Middle East Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
Middle East Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
Middle East Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
Africa Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
Africa Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
Africa Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
Africa Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
Rest of Middle East & Africa Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
Rest of Middle East & Africa Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
Rest of Middle East & Africa Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
Rest of Middle East & Africa Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
09

Latin America

  • In 2021, Latin America segment accounted for US$43.70 Bn and is expected grow with a CAGR of 5.19% over the forecast years.
  • In Latin America, Brazil accounted for US$18.11 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Argentina accounted for US$9.76 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Mexico accounted for US$7.99 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Colombia accounted for US$5.94 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Rest of Latin America accounted for US$1.89 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
Latin America Sulphonamides Market, By Country, 2019-2027 (USD billion)
Latin America Sulphonamides Market, By Country, 2019-2027 (USD billion)
Latin America Sulphonamides Market - Market Opportunity (USD billion), 2019, 2021 & 2027
Latin America Sulphonamides Market - Market Opportunity (USD billion), 2019, 2021 & 2027
Revenue Share (%), By Route of Administration - Latin America (2021)
Revenue Share (%), By Route of Administration - Latin America (2021)
Revenue Share (%), By Application - Latin America (2021)
Revenue Share (%), By Application - Latin America (2021)
Latin America Sulphonamides Market, By Country, 2019-2027 (USD billion)
Latin America Sulphonamides Market, By Country, 2019-2027 (USD billion)
Brazil Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
Brazil Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
Brazil Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
Brazil Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
Argentina Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
Argentina Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
Argentina Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
Argentina Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
Mexico Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
Mexico Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
Mexico Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
Mexico Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
Colombia Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
Colombia Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
Colombia Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
Colombia Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
Rest of Latin America Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
Rest of Latin America Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
Rest of Latin America Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
Rest of Latin America Sulphonamides Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
10

Company Analysis

  • AA Pharma Inc.
  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd
  • GlaxoSmithKline plc
  • Lexine Technochem Pvt. Ltd.
  • Mylan Pharmaceuticals
  • Pfizer Inc.
  • Teva Pharmaceuticals USA, Inc.